Advertisement

Topics

Endo International acquires Par Pharmaceutical

06:13 EDT 18 May 2015 | Current Partnering

This article has expired, however you can still download the PDF.
Preview:
Endo International and Par Pharmaceutical Holdings have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. The combination will create a ...

Other Sources for this Article

Original Article: Endo International acquires Par Pharmaceutical

NEXT ARTICLE

More From BioPortfolio on "Endo International acquires Par Pharmaceutical"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...